#news #biotech Inventiva raises €36M to prep for phase 3 NASH trial

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Inventiva raises €36M to prep for phase 3 NASH trial .Inventiva has raised €36 million ($44 million) to gear up for a phase 3 trial of pan-PPAR activator lanifibranor in NASH. The financing will see Inventiva through a period in which it will drop data from a phase 2b NASH trial and a two-year carcinogenicity study.

from FierceBiotech: Biotech https://ift.tt/2vaf6Mi